- Timing of elimination of the hepatitis C virus (HCV) in Canada’s provinces indicate 70% of provinces could reach the World Health Organization’s (WHO) HCV elimination target of 2030, however three of Canada’s provinces — two of them the most populous in the country — are off track to achieve this hepatitis C elimination goal.1
- Timely elimination would save 170 lives and $122.6 million in direct medical costs in these three provinces by 2030.1
- The Progress Report developed by Action Hepatitis Canada outlines key metrics on which to evaluate HCV elimination progress in canadaspecific to each province.2
- In canadathere are five priority populations and one age-cohort that carry the largest burden of HCV and are recognized as being affected the most by the virus.
MONTREAL, Nov. 24, 2022 /CNW/ – AbbVie (NYSE:ABBV) supports a wide range of efforts to help elevate and prioritize hepatitis C virus (HCV) elimination. With a recent publication indicating 70% of Canada’s provinces are on track to reach HCV elimination by the World Health Organization’s (WHO) initial proposed target of 20301it is important to turn our attention on those affected by the virus and acknowledge that infection with chronic HCV is a global public health concern.
In 2016, canada was one of the 194 countries that committed to support the World Health Organization’s (WHO) goal of eliminating viral hepatitis as a public health threat by 2030. With the remarkable progress in HCV therapy, offering the ability to cure patients, this goal seemed possible.
“With the decline in treatment across canadait is particularly critical we continue to monitor treatment levels to assess Canada’s progress to HCV elimination,” said Jordan J Feld, MD MPH, Interim…